Impact of Statin Dosing Intensity on Transaminase and Creatine Kinase

« Previous Next »The American Journal of Medicine
Volume 120, Issue 8 , Pages 706-712, August 2007

Krista M. Dale, PharmD
- The University of Connecticut Schools of Pharmacy, Hartford, Conn.
- Storrs and Farmington; and the Divisions of Cardiology, Hartford, Conn.
- Drug Information, Hartford Hospital, Hartford, Conn.
C. Michael White, PharmD
- The University of Connecticut Schools of Pharmacy, Hartford, Conn.
- Storrs and Farmington; and the Divisions of Cardiology, Hartford, Conn.
- Drug Information, Hartford Hospital, Hartford, Conn.
Nickole N. Henyan, PharmD
- The University of Connecticut Schools of Pharmacy, Hartford, Conn.
- Storrs and Farmington; and the Divisions of Cardiology, Hartford, Conn.
- Drug Information, Hartford Hospital, Hartford, Conn.
Jeffrey Kluger, MD
- The University of Connecticut Schools of Medicine, Hartford, Conn.
- Storrs and Farmington; and the Divisions of Cardiology, Hartford, Conn.
Craig I. Coleman, PharmD
- The University of Connecticut Schools of Pharmacy, Hartford, Conn.
- Storrs and Farmington; and the Divisions of Cardiology, Hartford, Conn.
- Drug Information, Hartford Hospital, Hartford, Conn.
- Requests for reprints should be addressed to Craig I. Coleman, PharmD, Assistant Professor of Pharmacy, University of Connecticut, and Director, Pharmacoeconomics and Outcomes Studies Group, Hartford Hospital, Hartford, CT 06102-5037.